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Abstract
Recent studies show that adrenergic agonists and inflammatory cytokines can stimulate skeletal 
muscle glucose uptake, but it is unclear if glucose oxidation is similarly increased. Thus, the 
objective of this study was to determine the effects of ractopamine HCl (β1 agonist), zilpaterol 
HCl (β2 agonist), TNFα, and IL-6 on glucose uptake and oxidation rates in unstimulated and 
insulin-stimulated soleus muscle strips from adult Sprague-Dawley rats. Effects on 
phosphorylation of Akt (phospho-Akt), p38 MAPK (phospho-p38), and p44/42 MAPK (phospho-
p44/42) was also determined. Incubation with insulin increased (P < 0.05) glucose uptake by 
~47%, glucose oxidation by ~32%, and phospho-Akt by ~238%. Insulin also increased (P < 0.05) 
phospho-p38, but only after 2 hours in incubation. Muscle incubated with β2 agonist alone 
exhibited ~20% less (P < 0.05) glucose uptake but ~32% greater (P < 0.05) glucose oxidation than 
unstimulated muscle. Moreover, co-incubation with insulin + β2 agonist increased (P < 0.05) 
glucose oxidation and phospho-Akt compared to insulin alone. Conversely, β1 agonist did not 
appear to affect basal or insulin-stimulated glucose metabolism, and neither β agonist affected 
phospho-p44/42. TNFα and IL-6 increased (P < 0.05) glucose oxidation by ~23% and ~33%, 
respectively, in the absence of insulin. This coincided with increased (P < 0.05) phospho-p38 and 
phospho-p44/42 but not phospho-Akt. Furthermore, co-incubation of muscle with insulin + either 
cytokine yielded glucose oxidation rates that were similar to insulin alone, despite lower (P < 
0.05) phospho-Akt. Importantly, cytokine-mediated increases in glucose oxidation rates were not 
concomitant with greater glucose uptake. These results show that acute β2 adrenergic stimulation, 
but not β1 stimulation, directly increases fractional glucose oxidation in the absence of insulin and 
synergistically increases glucose oxidation when combined with insulin. The cytokines, TNFα and 
IL-6, likewise directly increased glucose oxidation in the absence of insulin, but were not additive 
in combination with insulin and in fact appeared to disrupt Akt-mediated insulin signaling. Rather, 
cytokines appear to be acting through MAPKs to elicit effects on glucose oxidation. Regardless, 
Correspondence: Dustin Yates, PO Box 830908, Lincoln, NE 68583-0908, dustin.yates@unl.edu. 
Competing Interests
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Cytokine. Author manuscript; available in PMC 2018 August 01.
Published in final edited form as:
Cytokine. 2017 August ; 96: 107–113. doi:10.1016/j.cyto.2017.03.014.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
stimulation of glucose oxidation by these key stress factors did not rely upon greater glucose 
uptake, which may promote metabolic efficiency during acute stress by increasing fractional 
glucose oxidation without increasing total glucose consumption by muscle.
Graphical Abstract
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1. Introduction
Skeletal muscle comprises about 40% of total body mass in humans, yet it accounts for 
greater than 85% of the body’s insulin-stimulated glucose utilization [1, 2]. The role of 
insulin in metabolic regulation is well-understood, but muscle metabolism can be influenced 
by additional factors including catecholamines and cytokines [3–5]. Catecholamines (i.e. 
epinephrine, norepinephrine) are released into circulation by the adrenal medulla and act by 
binding to a large class of G protein-coupled adrenergic receptors (α1A, α1B, α1C, α2A, α2B, 
α2D, β1, β2, and β3) [6] located throughout the body. Thus, the impact that adrenergic 
stimulation has on a specific tissue is a function of the specific receptor type or types that it 
expresses. In skeletal muscle, β2 adrenergic receptors are the most highly-expressed 
isoform, but β1 receptors and to a lesser extent β3 and α1D receptors are also present [7, 8]. 
Growth studies in animals [9] have led to the development of isoform-specific β adrenergic 
growth promoters that are used as feed additives in the livestock industry to increase meat 
yield per animal [10]. In addition, reports show that β agonists are commonly used by 
athletes to boost muscle growth and athletic performance, despite being restricted by the 
World Anti-Doping Agency [11]. However, far less is known about the effects of β agonists 
on muscle metabolism. The seemingly complex effects of inflammatory cytokines on 
metabolism are likewise only beginning to be understood. Inflammation is known to cause 
insulin resistance [12], yet recent studies show that two major inflammatory cytokines, 
TNFα and IL-6, may stimulate glucose metabolism in muscle independent of their actions 
on insulin signaling [4, 13, 14]. Insulin increases glucose uptake in skeletal muscle through a 
well-characterized signaling cascade that begins with binding of its transmembrane tyrosine 
kinase receptor followed by sequential activation of the downstream targets, IRS1, PI3K, 
and Akt via phosphorylation [15]. This canonical pathway ultimately stimulates 
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translocation of glucose transporter, Glut4, to the cell membrane where it is imbedded and 
facilitates greater glucose passage into the muscle cell [16]. Phosphorylation of Akt appears 
to be a critical step in most insulin-regulated events, and thus the ratio of phosphorylated 
Akt to total Akt is considered to be a reliable indicator of insulin signaling [17]. In addition 
to the canonical PI3K/Akt-mediated signal transduction pathway, mitogen-activated protein 
kinases (MAPKs) have also been identified as activators of Glut4-mediated glucose uptake 
[18, 19]. Insulin-stimulated glucose oxidation rates have long been presumed to be 
proportional with glucose uptake rates [20], but we postulate that this relationship may not 
be maintained with the additional influence of adrenergic or inflammatory factors. 
Moreover, it is unclear whether these factors would regulate skeletal muscle glucose 
metabolism through direct effects or by altering insulin signaling. Thus, the objective of this 
study was to determine the respective impacts of β1 and β2 adrenergic agonists, TNFα, and 
IL-6 on glucose uptake and oxidation rates in intact soleus muscle strips isolated from adult 
rats. Furthermore, we sought to determine whether these effects were insulin-associated or 
insulin-independent by incubating muscle strips with each factor alone or in combination 
with insulin.
2. Materials and Methods
2.1. Animals and tissue isolation
The following experiments were approved by the Institutional Animal Care and Use 
Committee at the University of Nebraska-Lincoln. Animal studies were performed at the 
University of Nebraska-Lincoln Animal Science Complex, which is accredited by the 
American Association for Accreditation of Laboratory Animal Care.
Soleus muscles collected tendon-to-tendon from adult Sprague-Dawley rats (females 252.86 
± 14.93 g, males 378 ± 15.72 g) after decapitation under heavy isoflurane anesthesia were 
used to measure glucose uptake (n=10), glucose oxidation (n=9), and protein expression (n = 
8). Males and females were spread evenly across groups. Isolated soleus muscles were 
washed in ice-cold phosphate buffered saline (PBS; pH 7.4), and each muscle was dissected 
longitudinally (tendon to tendon) into 25–45 mg strips. For all experiments, muscle strips 
were pre-incubated for 1 hour at 37°C in gassed (95% O2, 5% CO2) Krebs-Henseleit 
bicarbonate buffer (KHB, pH 7.4; 0.1% bovine serum albumin; Sigma-Aldrich, St. Louis, 
MO) spiked with respective treatment (Table 1) and 5 mM D-glucose (Sigma-Aldrich, St. 
Louis, MO). Treatment concentrations were consistent with those previously described [4, 
21–25]. Muscle strips were then washed for 20 minutes in treatment-spiked KHB with no 
glucose. Pre-incubation and wash media for glucose uptake (but not glucose oxidation) 
experiments also contained 35 mM and 40 mM mannitol (Sigma-Aldrich), respectively. 
Glucose uptake and glucose oxidation rates were determined as described below. Protein 
analysis was performed in soleus strips from parallel incubations.
2.2. Glucose uptake
Glucose uptake rates were determined from intracellular accumulation of [3H]2-
deoxyglucose as previously described [26], with some modifications. After being pre-
incubated and washed, soleus strips were incubated at 37°C for 20 minutes in treatment-
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spiked KHB containing 1 mM [3H]2-deoxyglucose (300 μCi/mmol) and 39 mM [1-14C] 
mannitol (1.25 μCi/mmol). Muscle strips were then removed, thrice washed in ice-cold PBS, 
weighed, and lysed in 2M NaOH (Sigma-Aldrich) at 37°C for 1 hour. Lysates were vortexed 
and mixed with UltimaGold scintillation fluid, and specific activity of 3H and 14C was 
measured by liquid scintillation with a Beckman-Coulter 1900 TA LC counter (Brea, CA). 
Specific activity of the media was likewise determined in triplicate 10-μl aliquots mixed with 
500 μl distilled water and scintillation fluid. Mannitol concentrations were used to estimate 
the amount of extracellular fluid in each lysate, and intracellular accumulation of 2-
deoxyglucose was calculated as total 2-deoxyglucose in the lysate less the extracellular 
concentration. All radioactive compounds and scintillation fluids were purchased from 
Perkin-Elmer (Waltham, MA).
2.3. Glucose oxidation
Glucose oxidation rates were determined by oxidation of [14C-U] D-glucose as previously 
described [27], with some modifications. After being pre-incubated and washed, muscle 
strips were placed in one side of a sealed dual-well chamber and incubated at 37°C for 2 
hours in treatment-spiked KHB containing 5 mM [14C-U] D-glucose (0.25 μCi/mmol). 
NaOH (2M) was placed in the adjacent well to capture CO2. After 2 hours, chambers were 
cooled at −20°C for 2 minutes. HCl (2M; Sigma-Aldrich) was added to the media through a 
rubber seal on the top of the chamber, and the chambers were then incubated at 4°C for 1 
hour to release bicarbonate-bound CO2 from the media. Finally, chambers were unsealed 
and each muscle strip was washed and weighed. NaOH was collected from each chamber, 
mixed with UltimaGold scintillation fluid, and analyzed by liquid scintillation to determine 
specific activity of captured 14CO2. Specific activity of media was determined as described 
above.
2.4. Western Immunoblot
The respective activities of Akt and MAPKs were estimated by the proportions of 
phosphorylated target protein to total target protein as previously described [28–31], with 
minor modifications. Target protein concentrations were determined in soleus strips that 
were incubated in treatment-spiked KHB for 1 or 2 hours and then snap-frozen and stored at 
−80°C. Each muscle strip was thoroughly homogenized in 200 μl of 
radioimmunoprecipitation buffer containing manufacturer-recommended concentrations of 
Protease and Phosphatase Inhibitor (Thermo Fisher, Carlsbad, CA). Homogenates were then 
sonicated and centrifuged (14,000 × g for 5 minutes at 4°C), and supernatant was collected. 
Total protein concentrations were determined by Pierce BCA Protein Assay Kit (Thermo 
Fisher). Protein samples (35 μg) were boiled for 5 minutes at 95°C in BioRad 4x Laemmli 
Sample Buffer (BioRad, Hercules, CA) and then separated by SDS-polyacrylamide. Gels 
were transferred to polyvinylidene fluoride low florescence membranes (BioRad), which 
were incubated in Odyssey block solution (Li-Cor Biosciences, Lincoln, NE) for 1 hour at 
room temperature and then washed with 1X TBS-T (20 mM Tris-HCL + 150 mM NaCl 
+ 0.1% Tween 20). Membranes were subsequently incubated overnight at 4°C with one of 
the following rabbit antibodies diluted in Odyssey block solution + 0.05% Tween-20: anti-
Akt (1:1,000), anti-phospho-Akt (Ser473) (1:2,000), p44/42 MAPK (1:2,000), phospho-
p44/42 MAPK (Thr202/Tyr204) (1:1,000), p38 MAPK (1:1,000), or phospho-p38 MAPK 
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(Thr180/Tyr182) (1:1,000) (Cell Signaling, Danvers, MA). An IR800 goat anti-rabbit IgG 
secondary antibody (1:10,000 for Akt; 1:5,000 for MAPKs; Li-Cor) diluted in Odyssey 
block solution with 0.05% Tween-20 and 0.01% SDS was applied for 1 hour at room 
temperature. Blots were scanned on an Odyssey Infrared Imaging System and analyzed with 
Image Studio Lite Software (Li-Cor). For each protein of interest, phosphorylation rates 
were estimated by the proportions of phosphorylated protein to total protein (phospho-Akt, 
phospho-p38, phospho-p44/42, respectively).
2.5. Statistical analysis
All data were analyzed by ANOVA using the GLM procedure of SAS (SAS Institute, Cary, 
NC). Each data point was derived from the average of 2 technical replicates (i.e. in each 
experiment, each condition was studied in 2 muscle strips from each rat). Four separate 
metabolic experiments were performed, each with its own non-stimulated and insulin-only 
conditions as well as its own group of rats: glucose uptake with adrenergic agonists (n = 10), 
glucose uptake with cytokines (n = 10), glucose oxidation with adrenergic agonists (n = 9), 
and glucose oxidation with cytokines (n = 9). Likewise, separate groups of rats were used to 
determine protein concentrations in soleus muscle strips after 1 hour (n = 8) or 2 hours (n = 
4) in incubation. Sex of the donating rat was initially included as a covariate but did not 
affect any of the measured variables and was removed from the model. Data are presented as 
mean ± standard error.
3. Results
3.1. Glucose uptake and oxidation rates
3.1a. Adrenergic agonist stimulation—Glucose uptake and oxidation rates were 
greater (P < 0.05) for muscle incubated in media spiked with insulin compared to muscle 
incubated in un-spiked (basal) media (Figure 1). When muscle was incubated in media 
spiked with β1 agonist alone, glucose uptake and oxidation rates did not differ from 
unstimulated muscle (incubated in basal media). Moreover, when muscle was co-incubated 
with insulin + β1 agonist, glucose uptake and oxidation did not differ from muscle incubated 
with insulin alone. Conversely, muscle incubated with β2 agonist alone exhibited decreased 
(P < 0.05) glucose uptake and increased (P < 0.05) glucose oxidation compared to 
unstimulated muscle. Moreover, glucose uptake rates did not differ between muscle 
incubated with insulin alone or with insulin + β2 agonist, but glucose oxidation rates were 
greater (P < 0.05) for muscle incubated with insulin + β2 agonist compared to muscle 
incubated with either insulin alone or β2 agonist alone.
3.1b. Inflammatory cytokine stimulation—As with the adrenergic agonist studies, 
glucose uptake and oxidation rates were greater (P < 0.05) for muscle incubated with insulin 
compared to unstimulated muscle (Figure 2). Glucose uptake rates for muscle incubated 
with TNFα alone or IL-6 alone did not differ from rates in unstimulated muscle. Likewise, 
glucose uptake for muscle incubated with insulin + TNFα or insulin + IL-6 did not differ 
from muscle incubated with insulin alone. However, glucose oxidation rates for muscle 
incubated with TNFα alone or IL-6 alone were greater (P < 0.05) than for unstimulated 
muscle and, in fact, were similar to muscle incubated with insulin alone. Interestingly, 
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glucose oxidation rates for muscle incubated with insulin + TNFα or insulin + IL-6 did not 
differ from muscle incubated with insulin alone, TNFα alone, or IL-6 alone.
3.2. Akt phosphorylation
Muscle incubated with insulin exhibited greater (P < 0.05) phospho-Akt than unstimulated 
muscle after 1 and 2 hours in incubation (Figure 3). Conversely, phospho-Akt did not differ 
between unstimulated muscle and muscle incubated with β1 agonist, β2 agonist, TNFα, or 
IL-6 alone at either time point. After 1 hour, phospho-Akt did not differ between muscle 
incubated with insulin alone or insulin + β1 agonist but was greater (P < 0.05) in muscle 
incubated with insulin + β2 agonist. After 2 hours, phospho-Akt was greater (P < 0.05) in 
muscle incubated with either insulin + β1 agonist or insulin + β2 agonist than in 
unstimulated muscle but was less (P < 0.05) than in muscle incubated with insulin alone. 
Conversely, phospho-Akt was less (P < 0.05) in muscle incubated with insulin + TNFα or 
with insulin + IL-6 than in muscle incubated with insulin alone. In fact, phospho-Akt did not 
differ between unstimulated muscle and muscle incubated with insulin + IL-6.
3.3. MAPK phosphorylation
3.3a. p38 MAPK—After 1 hour in incubation, phospho-p38 did not differ between 
unstimulated muscle and muscle incubated with insulin alone, β1 agonist alone, β2 agonist 
alone, insulin + β1 agonist, insulin + β2 agonist, or insulin + IL-6 (Figure 4). However, 
muscle incubated with TNFα alone, IL-6 alone, or insulin + TNFα exhibited greater (P < 
0.05) phospho-p38 after 1 hour than unstimulated muscle or muscle incubated with insulin 
alone. After 2 hours, muscle incubated with insulin alone exhibited greater (P < 0.05) 
phospho-p38 than unstimulated muscle, but no other groups differed from unstimulated 
muscle.
3.3b. p44/42 MAPK—After 1 hour, phospho-p44/42 did not differ between unstimulated 
muscle and muscle incubated with insulin alone, β1 agonist alone, β2 agonist alone, or 
insulin + β1 agonist (Figure 5). However, phospho-p44/42 was lower (P < 0.05) in muscle 
incubated with insulin + β2 agonist compared to unstimulated muscle. Conversely, muscle 
incubated with TNFα alone, IL-6 alone, insulin + TNFα, or insulin + IL-6 exhibited greater 
(P < 0.05) phospho-p44/42 than unstimulated muscle or muscle incubated with insulin 
alone. No difference in phospho-p44/42 was observed among any groups after 2 hours in 
incubation.
4. Discussion
In this study, we show that acute stimulation of skeletal muscle with either β2 adrenergic 
agonist or inflammatory cytokines can increase glucose oxidation rate independent of insulin 
activity. Moreover, we show that these increases in glucose oxidation are not dependent 
upon concomitant increases in glucose uptake. Adrenergic effects on glucose metabolism 
were isoform-specific, as β2 agonist reduced basal glucose uptake, increased basal glucose 
oxidation, and synergistically enhanced insulin-stimulated glucose oxidation and Akt 
phosphorylation, but β1 agonist had no discernable effects on glucose metabolism or insulin 
signaling. Inflammatory cytokines antagonized insulin signaling but simultaneously 
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stimulated skeletal muscle glucose oxidation, seemingly via MAPK-mediated signaling 
pathways. Together, our findings indicate that acute exposure to these stress factors can 
increase glucose oxidation independently of changes in glucose uptake and insulin signaling. 
This demonstrates a role for stress mediators in regulation of energy homeostasis that may 
be important in both stressed and unstressed states.
Acute β2-specific adrenergic stimulation in the absence of insulin had contrasting effects on 
skeletal muscle glucose uptake and oxidation rates, as glucose uptake was reduced but 
glucose oxidation was improved. Previous studies in humans and animals have indicated that 
glucose oxidation rates are typically proportional to glucose utilization rates across a variety 
of physiological conditions [32, 33], yet our findings show that fractional glucose oxidation 
by soleus muscle grew substantially during acute β2 adrenergic stimulation, independent of 
the rate of glucose uptake. This may help to explain previously reported reductions in 
(whole-body) fractional glucose oxidation rates in growth-restricted fetal sheep [34], which 
exhibit reduced expression of β2 receptors in muscle, fat, and other tissues [35–38]. In 
addition to increasing basal glucose oxidation rates, acute β2 adrenergic stimulation 
synergistically enhanced the effects of insulin on skeletal muscle glucose oxidation, as the 
two factors together elicited a greater combined impact than either factor individually. The 
additive effect of β2 adrenergic agonist and insulin appeared to be mechanistically facilitated 
by greater activation of the canonical signaling component, Akt, which is a key mediator for 
most of insulin’s intracellular effects [39]. Conversely, β1 adrenergic stimulation produced 
no such additive effect with insulin for glucose uptake or oxidation and did not appear to 
have any direct impact on the metabolic outputs measured in this study. One possible 
explanation for the distinctly different impacts of the respective β agonists in the present 
study is the substantially lower expression of β1 adrenergic receptors in muscle relative to 
β2 receptors. Kim et al. [7] showed that the β1 isoform comprises only about 15–21% of the 
total β receptor population expressed by the soleus muscle of the adult rat and that the β2 
isoform can account for essentially all β receptors in some muscles. Similar β receptor 
populations were found in human muscle biopsies [40, 41]. The present findings also help 
explain greater muscle growth efficiency in food animals supplemented with dietary β2 
agonist compared to β1 agonist [42–44].
Acute exposure of muscle to the inflammatory cytokines, TNFα and IL-6, antagonized 
insulin signaling, as expected, but stimulated glucose oxidation directly. Inflammation has 
long been linked to insulin resistance [45–47], and this effect was evident in our study by the 
reduction of insulin-stimulated Akt phosphorylation after 2-hour exposure to either TNFα or 
IL-6. Despite this apparent impairment of insulin signaling, glucose uptake and oxidation 
rates were nonetheless similar between muscle stimulated with insulin alone or co-
stimulated with insulin and cytokines, indicating direct stimulation by cytokines. Moreover, 
cytokines were able to stimulate glucose oxidation in the absence of insulin. Together, these 
results show that inflammatory cytokines increase glucose metabolism in skeletal muscle 
independently of their impact on canonical insulin signaling. Furthermore, we show that the 
direct effects on glucose oxidation are not dependent upon parallel changes in glucose 
uptake. Previous studies have shown that short-term exposure to IL-6 acutely increases 
glucose uptake in humans and in human muscle biopsies via AMPK-mediated signaling 
pathways rather than PI3K or Akt-mediated pathways [4, 48, 49]. Acute exposure of culture-
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derived C2C12 myotubes to TNFα likewise increased glucose uptake, as well as glucose 
utilization [14]. It is unclear why cytokines did not increase basal glucose uptakes rates in 
the present study, but one possible explanation is the relatively short exposure time, as other 
studies have found that similar durations of IL-6 stimulation required co-incubation with the 
IL-6 receptor in order to observe increased glucose uptake [48, 50]. Nevertheless, it is 
noteworthy that greater glucose oxidation was independent of glucose uptake rates in the 
present study. Glund et al. [4] previously found a moderate increase in glucose oxidation 
rates in IL-6 stimulated human muscle biopsies that was attributed to a concomitant increase 
in glucose uptake. However, we observed an ~36% increase in glucose oxidation with no 
increase in glucose uptake. Cytokine-stimulated increases in glucose oxidation were 
paralleled by greater phosphorylation of p38 and p44/42 MAPKs. Greater MAPK activity 
has been associated with increased glucose oxidation in cardiac myocytes [51] and may 
likewise represent an Akt-independent mechanism for increasing glucose oxidation in 
skeletal muscle, much the same way that greater AMPK activation is thought to increase 
glucose uptake [4, 48, 50].
5. Conclusions
Our findings show that acute exposure of adult rat soleus muscle to β2 adrenergic agonist or 
to inflammatory cytokines stimulates greater glucose oxidation. Furthermore, we found that 
this effect was independent of insulin action and was not contingent upon increases in 
glucose uptake. In fact, muscle stimulated with TNFα and IL-6 showed evidence of 
decreased insulin signaling but greater MAPK activity, indicating that MAPKs may be 
important mediators of cytokine-induced glucose oxidation. Conversely, β2 adrenergic 
stimulation enhanced basal and insulin-stimulated glucose oxidation without affecting Akt 
or MAPK activity. The increase in fractional glucose oxidation rates appears to indicate 
greater skeletal muscle metabolic efficiency at the onset of the stress response, which may 
help to improve outcomes of acute adverse events.
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Highlights
• Inflammatory cytokines and β2 agonists stimulate skeletal muscle glucose 
oxidation.
• Greater oxidation is independent of glucose uptake rates or insulin activity.
• β2 agonists also enhance insulin-stimulated glucose oxidation and Akt 
activation.
• TNFα and IL-6 impaired insulin action but increased glucose oxidation 
directly.
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Figure 1. 
Glucose uptake and oxidation rates in primary rat soleus muscle during 20-minute (n = 10) 
or 2-hour incubation (n = 9), respectively, with isoform-specific adrenergic 
agonists. a,b,c,dmeans with different superscripts differ (P < 0.05).
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Figure 2. 
Glucose uptake and oxidation rates in primary rat soleus muscle during 20-minute (n = 10) 
or 2-hour incubation (n = 9), respectively, with inflammatory cytokines. a,bmeans with 
different superscripts differ (P < 0.05).
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Figure 3. 
Akt phosphorylation in primary rat soleus muscle after 1 hour (n = 8) or 2 hours (n = 4) in 
incubation with isoform-specific adrenergic agonists or cytokines. a,b,c,d,e,fmeans with 
different superscripts differ (P < 0.05).
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Figure 4. 
p38 MAPK phosphorylation in primary rat soleus muscle after 1 hour (n = 8) or 2 hours (n = 
4) in incubation with isoform-specific adrenergic agonists or cytokines. a,bmeans with 
different superscripts differ (P < 0.05).
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Figure 5. 
p44/42 MAPK phosphorylation in primary rat soleus muscle after 1 hour (n = 8) or 2 hours 
(n = 4) in incubation with isoform-specific adrenergic agonists or cytokines. a,b,cmeans with 
different superscripts differ (P < 0.05).
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